Ss. Witkin et al., INDUCTION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN RHESUS-MONKEYS AFTER INTRAAMNIOTIC INFECTION WITH GROUP-B STREPTOCOCCI OR INTERLEUKIN-1 INFUSION, American journal of obstetrics and gynecology, 171(6), 1994, pp. 1668-1672
OBJECTIVE: Interleukin-1 receptor antagonist is a natural inhibitor of
interleukin-1, a cytokine implicated in the initiation of preterm lab
or after intraamniotic infection. The effects of intraamniotic infecti
on and interleukin-1 infusion on the appearance of interleukin-1 recep
tor antagonist in amniotic fluid and fetal and maternal plasma were as
sessed with a monkey model. STUDY DESIGN: On day 130 of pregnancy four
chronically catheterized rhesus macaques received intraamniotic inocu
lations of group B streptococci, three monkeys received intraamniotic
infusions of recombinant human interlukin-1 beta, and three monkeys re
ceived buffered saline solution infusions. At timed intervals samples
of amniotic fluid, fetal plasma, and maternal plasma were assayed for
interleukin-1 beta and interleukin-1 receptor antagonist by immunoassa
ys. Uterine activity was continuously monitored by intraamniotic press
ure catheters and by electromyographic activity. RESULTS: Interleukin-
1 receptor antagonist, but not interleukin-1 beta, was present in the
amniotic fluids of all monkeys before intervention. Infection induced
the appearance of interleukin-1 beta and an increase in interleukin-1
receptor antagonist in the amniotic fluid. Interleukin-1 beta infusion
resulted in a similar increase in the intraamniotic concentration of
interleukin-1 receptor antagonist. Both infection and interleukin-1 be
ta infusion were followed by the transient appearance of interleukin-1
receptor antagonist in the plasma of all fetuses. The subsequent decr
ease in plasma levels was paralleled by increased amniotic fluid level
s of interleukin-1 receptor antagonist. Interleukin-1 beta and interle
ukin-1 receptor antagonist were not detected in maternal plasma. Both
infection and interleukin-1 infusion induced preterm labor in all trea
ted animals. CONCLUSIONS: Interleukin-1 receptor antagonist is a norma
l component of monkey amniotic fluid. Intraamniotic infection or the a
ppearance of interleukin-1 beta in the amniotic fluid results in incre
ased production of interleukin-1 receptor antagonist. Under physiologi
c conditions interleukin-1 receptor antagonist in amniotic fluid may i
nhibit interleukin-1-induced preterm labor.